AAS
TGTX icon

Ameritas Advisory Services’s TG Therapeutics TGTX Stock Holding History

Ameritas Advisory Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Buy
+210
New +$8.59K ﹤0.01% 1446
2025
Q4 		– Sell
-700
Closed -$25.3K – 1992
2025
Q3 		$25.3K Hold
700
– – ﹤0.01% 1359
2025
Q2 		$25.2K Buy
+700
New +$26.1K ﹤0.01% 1641
2023
Q2 		– Sell
-1,125
Closed -$25.5K – 2331
2023
Q1 		$25.5K Buy
+1,125
New +$17.1K ﹤0.01% 1535

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Ameritas Advisory Services's TGTX Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in TG Therapeutics (TGTX) in Q2 2026: 210 shares worth $11.5K. The stake represents ﹤0.01% of the portfolio and ranks #1446 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in TGTX as recently as Q3 2025.

Ameritas Advisory Services first reported a position in TGTX in Q1 2023 and has held it in 4 quarters since. The position peaked at $25.5K in Q1 2023. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Ameritas Advisory Services held 210 shares of TG Therapeutics worth $11.5K as of Q2 2026.
  • TG Therapeutics was a new Ameritas Advisory Services position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1446 holding.
  • Ameritas Advisory Services first reported a position in TG Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Ameritas Advisory Services's TG Therapeutics position peaked at $25.5K in Q1 2023.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.